InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
9
T+90 hit rate
60%
T+90 mean return
-1.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Tessier-Lavigne Marc, Director. Director active across 2 companies, notably Denali Therapeutics Inc.. In total, 25 disclosures have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €5.2m. Activity tracked since 3 May 2021. The latest transaction was filed on 3 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations25 total
6,037 shares0Common StockSEC:0001714899-25-000136:0
5,967 shares0Common StockSEC:0001714899-24-000140:0
4,216 shares0Common StockSEC:0001714899-23-000099:0
165 shares0Common StockSEC:0001883850-23-000015:0
165 shares0Common StockSEC:0001883850-23-000014:0
20,000 shares@ US$30.486.7% of flowCommon StockSEC:0001714899-22-000148:0
8,748 shares@ US$30.203.0% of flowCommon StockSEC:0001714899-22-000146:0
3,798 shares@ US$413.3315.8% of flowCommon StockSEC:0001883850-22-000072:0
15,577 shares@ US$30.745.6% of flowCommon StockSEC:0001714899-22-000133:0
19,900 shares@ US$31.617.2% of flowCommon StockSEC:0001714899-22-000131:0
19,800 shares@ US$35.607.9% of flowCommon StockSEC:0001714899-22-000109:0
8,402 shares@ US$33.402.9% of flowCommon StockSEC:0001714899-22-000101:0
13,250 shares@ US$31.10014.5% of flowCommon StockSEC:0001628280-22-018113:0
5,986 shares0Common StockSEC:0001714899-22-000096:0
8,402 shares@ US$33.400.0099% mcap4.7% of flowCommon StockSEC:0001714899-22-000061:0
7,439 shares@ US$380.950.0035% mcap30.2% of flowCommon StockSEC:0001708138-22-000027:0
4,361 shares@ US$374.120.0020% mcap17.5% of flowCommon StockSEC:0001708138-22-000020:0
191 shares0Common StockSEC:0001883850-22-000008:0
300,000 shares0Common StockSEC:0001714899-21-000117:0
3,784 shares@ US$371.400.0017% mcap14.6% of flowCommon StockSEC:0001237899-21-000027:0
4,250 shares@ US$273.670.0013% mcap11.6% of flowCommon StockSEC:0001708138-21-000080:0
39,303 shares@ US$18.000.023% mcap10.6% of flowCommon StockSEC:0001209191-21-038978:0
2,074 shares0Common StockSEC:0001209191-21-038393:0
37,957 shares@ US$60.1330.072% mcap34.2% of flowCommon StockSEC:0001209191-21-035548:0
3,139 shares@ US$60.080.0061% mcap2.9% of flowCommon StockSEC:0001209191-21-030304:0
25 of 25 declarations
About Tessier-Lavigne Marc
Marc Tessier-Lavigne is an executive at Denali Therapeutics Inc.
